出版社：Consejo Superior de Investigaciones Científicas
摘要：This paper analyses the normative justification of the adoption of randomized clinical trials as a methodological standard for pharmaceutical policy by the British health authorities in 1946. Through a discussion of the interests of the different parties involved in the process (doctors, patients, pharmaceutical companies and the State) I argue that randomization was adopted namely as an impartial mechanism to allocate treatments, even if its statistical foundations were not properly understood. I contend that such justification is still valid.
关键词：randomization;clinical trials;bioethics;British health policy;Aleatorización;ensayos clínicos;bioética;política sanitaria británica
